bf/NASDAQ:ADMP_icon.jpeg

NASDAQ:ADMP

Adamis Pharmaceuticals Corporation

  • Stock

USD

Last Close

0.77

07/09 19:59

Market Cap

7.25M

Beta: 1.23

Volume Today

119.48K

Avg: 1.54M

PE Ratio

−0.12

PFCF: −0.54

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-13.57M
-
-19.44M
43.22%
-25.54M
31.39%
-39.01M
52.73%
-29.31M
24.87%
-49.39M
68.53%
-45.83M
7.21%
-26.48M
42.22%
depreciation and amortization
990.29K
-
2.53M
155.95%
3.06M
20.87%
3.10M
1.15%
2.94M
4.98%
3.61M
22.50%
1.44M
60.20%
1.48M
3.33%
deferred income tax
-4.59M
-
-343.55K
92.51%
-372.47K
8.42%
1.21M
424.01%
14.49M
1,100.89%
9.21M
36.44%
stock based compensation
2.51M
-
4.76M
89.50%
6.06M
27.32%
6.54M
7.88%
5.87M
10.22%
4.42M
24.67%
1.98M
55.14%
-340.27K
117.16%
change in working capital
13.60K
-
-3.05M
22,551.31%
487.98K
115.99%
-6.54M
1,441.04%
-616.42K
90.58%
5.13M
931.60%
-10.80M
310.66%
-1.34M
87.58%
accounts receivables
-363K
-
-87.63K
75.86%
-421.01K
380.45%
-745.15K
76.99%
737.93K
199.03%
-573.34K
177.70%
-238.49K
58.40%
inventory
1.89K
-
-882.49K
46,767.95%
-4.98M
464.34%
24.76K
100.50%
-3.42M
13,892.08%
-236.15K
93.09%
-820.17K
247.30%
accounts payables
-289.22K
-
-1.71M
490.19%
587.15K
134.40%
846.12K
44.11%
574.51K
32.10%
-726.71K
226.49%
1.91M
362.64%
3.93M
106.12%
other working capital
302.81K
-
-984.65K
425.16%
870.95K
188.45%
-1.99M
328.35%
-470.54K
76.34%
8.53M
1,912.85%
-11.90M
239.48%
-4.22M
64.56%
other non cash items
-278.43K
-
-2.75M
888.53%
1.14M
141.43%
3.63M
218.45%
18.46K
99.49%
843.67K
4,470.25%
6.21M
636.31%
775.36K
87.52%
net cash provided by operating activities
-10.34M
-
-21.16M
104.73%
-15.13M
28.49%
-32.66M
115.81%
-19.89M
39.11%
-20.90M
5.11%
-37.79M
80.78%
-25.90M
31.45%
investments in property plant and equipment
-121.10K
-
-2.09M
1,625.03%
-3.54M
69.23%
-2.87M
18.92%
-946.21K
66.99%
-1.22M
29.30%
-680.42K
44.39%
acquisitions net
381.88K
-
purchases of investments
sales maturities of investments
other investing activites
-32
-
-24.74K
77,203.13%
1.51M
-
4.16M
176.48%
net cash used for investing activites
260.75K
-
-2.09M
900.76%
-3.54M
69.32%
-2.87M
18.92%
-946.21K
66.99%
282.74K
129.88%
3.48M
1,132.21%
debt repayment
-324.65K
-
-2.33M
617.95%
-487.90K
79.07%
-496.79K
1.82%
-90.62K
81.76%
-17.03K
-
common stock issued
10.57M
-
10.22M
3.31%
16.02M
56.83%
37.62M
134.81%
12.79M
66.01%
18.23M
42.54%
51.75M
183.90%
300K
99.42%
common stock repurchased
dividends paid
other financing activites
75.59K
-
12.02M
15,806.02%
16.77M
39.45%
1.75M
-
2.19M
24.56%
2.03K
99.91%
net cash used provided by financing activities
10.64M
-
21.91M
105.93%
30.46M
38.98%
37.13M
21.91%
12.29M
66.90%
19.89M
61.84%
53.94M
171.14%
285K
99.47%
effect of forex changes on cash
68.56K
-
-7.76K
111.32%
net change in cash
305.98K
-
1.02M
231.75%
13.24M
1,203.99%
938.94K
92.91%
-10.46M
1,214.13%
-1.96M
81.31%
16.50M
943.96%
-22.14M
234.16%
cash at beginning of period
3.77M
-
4.08M
8.11%
5.10M
24.88%
18.33M
259.76%
19.27M
5.12%
8.81M
54.28%
6.75M
23.40%
23.25M
244.51%
cash at end of period
4.08M
-
5.10M
24.88%
18.33M
259.76%
19.27M
5.12%
8.81M
54.28%
6.86M
22.19%
23.25M
239.16%
1.11M
95.22%
operating cash flow
-10.34M
-
-21.16M
104.73%
-15.13M
28.49%
-32.66M
115.81%
-19.89M
39.11%
-20.90M
5.11%
-37.79M
80.78%
-25.90M
31.45%
capital expenditure
-121.10K
-
-2.09M
1,625.03%
-3.54M
69.23%
-2.87M
18.92%
-946.21K
66.99%
-1.22M
29.30%
-680.42K
44.39%
free cash flow
-10.34M
-
-21.28M
105.90%
-17.22M
19.08%
-36.19M
110.16%
-22.75M
37.14%
-21.85M
3.98%
-39.01M
78.55%
-26.58M
31.86%

All numbers in USD (except ratios and percentages)